These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33377185)

  • 21. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning.
    García-Gigorro R; Renes-Carreño E; Pérez-Vela JL; Marín-Mateos H; Gutiérrez J; Corrés-Peiretti MA; Delgado JF; Pérez-de la Sota E; Cortina-Romero JM; Montejo-González JC
    Med Intensiva; 2017 Dec; 41(9):513-522. PubMed ID: 28259366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect evaluation of bedside ultrasound monitoring of left ventricular functional parameters combined with clinical indicators on veno-arterial extracorporeal membrane oxygenation].
    Yi R; Guo J; Zhou Q; Song H; Zhou Y; Jiang N; Yao X; Guo R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):329-333. PubMed ID: 33834975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Levosimendan on Endothelial Function and Hemodynamics During Weaning From Veno-Arterial Extracorporeal Life Support.
    Sangalli F; Avalli L; Laratta M; Formica F; Maggioni E; Caruso R; Cristina Costa M; Guazzi M; Fumagalli R
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1449-1453. PubMed ID: 27495966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock.
    Akin S; Dos Reis Miranda D; Caliskan K; Soliman OI; Guven G; Struijs A; van Thiel RJ; Jewbali LS; Lima A; Gommers D; Zijlstra F; Ince C
    Crit Care; 2017 Oct; 21(1):265. PubMed ID: 29073930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit.
    Vally S; Ferdynus C; Persichini R; Bouchet B; Braunberger E; Lo Pinto H; Martinet O; Vandroux D; Aujoulat T; Allyn J; Allou N
    Ann Intensive Care; 2019 Feb; 9(1):24. PubMed ID: 30707314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.
    Vallabhajosyula S; O'Horo JC; Antharam P; Ananthaneni S; Vallabhajosyula S; Stulak JM; Eleid MF; Dunlay SM; Gersh BJ; Rihal CS; Barsness GW
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006930. PubMed ID: 30354593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock.
    Aissaoui N; Luyt CE; Leprince P; Trouillet JL; Léger P; Pavie A; Diebold B; Chastre J; Combes A
    Intensive Care Med; 2011 Nov; 37(11):1738-45. PubMed ID: 21965097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper.
    Cholley B; Levy B; Fellahi JL; Longrois D; Amour J; Ouattara A; Mebazaa A
    Crit Care; 2019 Nov; 23(1):385. PubMed ID: 31783891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-stage weaning strategy using veno-veno-arterial perfusion for patients on extracorporeal membrane oxygenation following cardiogenic shock.
    Haldenwang PL; Baumann A; Elghannam M; Schlömicher M; Buchwald D; Klak K; Strauch JT
    Perfusion; 2019 Nov; 34(8):689-695. PubMed ID: 31081459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Levosimendan and Milrinone for ECLS Weaning in Patients After Cardiac Surgery-A Retrospective Before-and-After Study.
    Jacky A; Rudiger A; Krüger B; Wilhelm MJ; Paal S; Seifert B; Spahn DR; Bettex D
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2112-2119. PubMed ID: 29748076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer of Patients With Cardiogenic Shock Using Veno-Arterial Extracorporeal Membrane Oxygenation.
    Ali JM; Vuylsteke A; Fowles JA; Pettit S; Salaunkey K; Bhagra S; Lewis C; Parameshwar J; Kydd A; Patvardhan C; Jones N; Rubino A; Abu-Omar Y; Sudarshan C; Tsui S; Catarino P; Jenkins DP; Berman M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):374-382. PubMed ID: 31221511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary Use of Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Acute Coronary Syndrome.
    Negi SI; Sokolovic M; Koifman E; Kiramijyan S; Torguson R; Lindsay J; Ben-Dor I; Suddath W; Pichard A; Satler L; Waksman R
    J Invasive Cardiol; 2016 Feb; 28(2):52-7. PubMed ID: 26689415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.
    Sun T; Guy A; Sidhu A; Finlayson G; Grunau B; Ding L; Harle S; Dewar L; Cook R; Kanji HD
    J Crit Care; 2018 Apr; 44():31-38. PubMed ID: 29040883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock.
    Lüsebrink E; Orban M; Kupka D; Scherer C; Hagl C; Zimmer S; Luedike P; Thiele H; Westermann D; Massberg S; Schäfer A; Orban M
    Eur Heart J; 2020 Oct; 41(38):3753-3761. PubMed ID: 33099278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock-A six-year service evaluation.
    Charlesworth M; Garcia M; Head L; Barker JM; Ashworth AD; Barnard JB; Feddy L; Venkateswaran RV
    Artif Organs; 2020 Jul; 44(7):709-716. PubMed ID: 31970800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].
    Loforte A; Pilato E; Martin Suarez S; Folesani G; Jafrancesco G; Castrovinci S; Cefarelli M; Potena L; Magnani G; Grigioni F; Caramelli F; Frascaroli G; Di Bartolomeo R; Marinelli G
    G Ital Cardiol (Rome); 2014 Oct; 15(10):577-85. PubMed ID: 25424022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan for VA-ECMO weaning: the silver lining.
    Kaddoura R; Mohamed Ibrahim MI; Omar A
    ESC Heart Fail; 2022 Feb; 9(1):236-240. PubMed ID: 34873878
    [No Abstract]   [Full Text] [Related]  

  • 40. [Predictors of in-hospital mortality in adult postcardiotomy cardiacgenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation].
    Xie HX; Yang F; Jiang CJ; Wang JH; Hou DB; Wang JG; Wang H; Hou XT
    Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(12):929-933. PubMed ID: 28355755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.